Sandbox gc: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
 
(22 intermediate revisions by the same user not shown)
Line 1: Line 1:
{| class="wikitable"
==Definition of Multivessel Disease==
!  !! Category !! Topic !! Calculators !! Purpose !! Author !! Reviewer !! Status
 
|-
For AEGIS-II inclusion criteria #5, multivessel disease criteria can be met by findings on the cardiac catheterization for the index MI, a prior cardiac catheterization, or both:
| Formula || CARDIOLOGY ||  || 6 Minute Walk Distance || Calculates reference values for distance walked, as a measure of functional status. ||  ||  ||
* Index MI cardiac catheterization: 50% or greater stenosis of the left main or at least <b><u>2</u></b> coronary artery territories (LAD, LCX, RCA) (prior to any interventions performed)
|-
* Prior cardiac catheterization: 50% or greater stenosis of left main or at least <b><u>2</u></b> coronary artery territories (LAD, LCx, RCA) (prior to any interventions performed)
| Formula || CARDIOLOGY ||  || Absolute Reticulocyte Count & Reticulocyte Index || Assesses appropriate response to anemia, frequently in sickle cell patients. ||  ||  || Tier 2
* Both: Index MI cardiac catheterization with 1 vessel with 50% or greater stenosis (prior to any interventions performed) <b><u>AND</u></b> prior PCI of at least 1 vessel different from index MI vessel
|-
* Prior multivessel CABG
|  || CARDIOLOGY ||  || ACC/AHA Heart Failure Staging || Describes stages of heart failure and provides recommendations for therapy by stage. ||  ||  || Tier 1
   
|-
Multivessel disease requires a 50% or greater stenosis in at least 2 of the 3 major epicardial artery territories (LAD, LCx, RCA) or the left main vessel. Branch vessel disease may qualify as part of the territory of that branch vessel (for example, a diagonal vessel is considered part of the LAD territory). For the purpose of this study, the ramus is considered part of the Left Circumflex artery territory. If a branch vessel is used as a qualifying vessel, that branch should be of large enough size to potentially undergo revascularization if clinically indicated, e.g. >2mm vessel size.
| Formula || CARDIOLOGY || Coronary artery disease || ACEF II risk score for cardiac surgery ||  ||  ||  ||
 
|-
==MVD Tool==
|  || CARDIOLOGY || Coronary artery disease || ACTION ICU score for intensive care in NSTEMI || Predicts risk of NSTEMI complications requiring ICU care. ||  ||  || Tier 2
 
|-
{|
|  || CARDIOLOGY ||  || Acute Decompensated Heart Failure National Registry (ADHERE) Algorithm || Predicts in-hospital mortality in patients with heart failure (HF). ||  ||  ||
{{#Widget:MVD5}}
|-
|  || CARDIOLOGY || Coronary artery disease || ADAPT protocol for cardiac event risk ||  ||  ||  || Tier 2
|-
|  || CARDIOLOGY || DVT || AMUSE score calculator ||  || Sadaf Sharfaei ||  || Complete
|-
|  || CARDIOLOGY || Coronary artery disease || Aortic dissection detection risk score (ADD-RS) ||  ||  ||  || Tier 2
|-
|  || CARDIOLOGY ||  || ASCVD (Atherosclerotic Cardiovascular Disease) 2013 Risk Calculator from AHA/ACC ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || ASCVD (Atherosclerotic Cardiovascular Disease) Risk Algorithm including Known ASCVD from AHA/ACC ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || ASTRAL Score for Ischemic StrokeUPDATED ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || ATRIA Bleeding Risk Score ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || ATRIA Stroke Risk Score ||  ||  ||  ||
|-
|  || CARDIOLOGY || PE || Bova score for pulmonary embolism complications ||  ||  ||  || Tier 1
|-
|  || CARDIOLOGY ||  || Brugada Criteria for Ventricular Tachycardia ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || CAGE Questions for Alcohol Use ||  ||  ||  ||
|-
|  || CARDIOLOGY || Coronary artery disease || Canadian Cardiovascular Society (CCS) angina grade ||  ||  ||  || Tier 2
|-
|  || CARDIOLOGY ||  || Canadian Syncope Risk Score ||  ||  ||  ||
|-
|  || CARDIOLOGY || VTE || Caprini score calculator ||  || Sadaf Sharfaei ||  || Complete
|-
|  || CARDIOLOGY ||  || Cardiac Anesthesia Risk Evaluation Score (CARE) ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || Cardiac Output (Fick’s Formula) ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || CART (Cardiac Arrest Risk Triage) Score ||  ||  ||  ||
|-
| Popular || CARDIOLOGY || Atrial fibrillation || CHA2DS2-VASc Score ||  || Sadaf Sharfaei ||  || Complete
|-
| Popular || CARDIOLOGY || Atrial fibrillation || CHADS2 score ||  || Sadaf Sharfaei ||  || Complete
|-
|  || CARDIOLOGY ||  || Charlson Comorbidity Index (CCI) ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || Cincinnati Prehospital Stroke Severity Scale (CP-SSS) ||  ||  ||  ||
|-
| Formula || CARDIOLOGY || ECG || Corrected QT interval (QTc) ||  ||  ||  ||
|-
|  || CARDIOLOGY || Coronary artery disease || CRUSADE score for post-mi bleeding risk ||  ||  ||  || Tier 2
|-
|  || CARDIOLOGY || VTE || Dash prediction score for recurrent vte ||  ||  ||  || Tier 1
|-
|  || CARDIOLOGY || Coronary artery disease || Dual Antiplatelet Therapy (DAPT) score ||  ||  ||  || Tier 1
|-
|  || CARDIOLOGY ||  || Duke Activity Status Index (DASI) ||  ||  || ||
|-
|  || CARDIOLOGY ||  || Duke Criteria for Infective Endocarditis ||  ||  ||  ||
|-
| Formula || CARDIOLOGY || Coronary artery disease || Duke treadmill score ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || EGSYS (Evaluation of Guidelines in SYncope Study) Score for Syncope ||  ||  ||  ||
|-
|  || CARDIOLOGY || Coronary artery disease || Emergency Department Assessment of Chest Pain Score (EDACS) ||  ||  ||  || Tier 2
|-
|  || CARDIOLOGY ||  || Emergency Heart Failure Mortality Risk Grade (EHMRG) ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || Framingham Heart Failure Diagnostic Criteria ||  ||  ||  ||
|-
| Formula || CARDIOLOGY || Coronary artery disease || Framingham Risk Score for hard coronary heart disease ||  ||  ||  ||
|-
|  || CARDIOLOGY || PE || Geneva score calculator ||  || Sadaf Sharfaei ||  || Complete
|-
|  || CARDIOLOGY ||  || GO-FAR (Good Outcome Following Attempted Resuscitation) Score ||  ||  ||  ||
|-
|  || CARDIOLOGY || Coronary artery disease || Grace Risk Score for All-Cause Mortality From Discharge to 6 Months ||  ||  ||  || Tier 1
|-
|  || CARDIOLOGY || Coronary artery disease || Grace Risk Score for In-Hospital Mortality ||  ||  ||  || Tier 1
|-
|  || CARDIOLOGY ||  || Gupta Perioperative Risk for Myocardial Infarction or Cardiac Arrest (MICA) ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || GWTG-Heart Failure Risk Score ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || H2FPEF Score for Heart Failure with Preserved Ejection FractionNEW ||  ||  ||  ||
|-
|  || CARDIOLOGY || DVT || HAMILTON score calculator ||  || Sadaf Sharfaei ||  || Complete
|-
| Popular || CARDIOLOGY || Atrial fibrillation || HAS-BLED score ||  || Sadaf Sharfaei ||  || Complete
|-
|  || CARDIOLOGY ||  || HEART Pathway for Early Discharge in Acute Chest Pain ||  ||  ||  ||
|-
| Popular || CARDIOLOGY || MACE || HEART score for major cardiac events ||  ||  ||  || Tier 1
|-
|  || CARDIOLOGY ||  || HEMORR₂HAGES Score for Major Bleeding Risk ||  ||  ||  ||
|-
|  || CARDIOLOGY || VTE || HERDOO2 rule for discontinuing anticoagulation in unprovoked vte ||  ||  ||  || Tier 1
|-
|  || CARDIOLOGY || PE || Hestia criteria for outpatient pulmonary embolism treatment ||  ||  ||  || Tier 2
|-
|  || CARDIOLOGY || Bleeding || IMPROVE bleeding risk score ||  ||  ||  || Tier 1
|-
|  || CARDIOLOGY || VTE || IMPROVE risk score calculator ||  || Sadaf Sharfaei ||  || Complete
|-
|  || CARDIOLOGY || VTE || IMPROVEDD risk score calculator ||  || Sadaf Sharfaei ||  || Complete
|-
|  || CARDIOLOGY ||  || Indian Takayasu Clinical Activity Score (ITAS2010) ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || Infective Endocarditis (IE) Mortality Risk Score ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || Jones Criteria for Acute Rheumatic Fever Diagnosis ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || Kawasaki Disease Diagnostic Criteria ||  ||  ||  ||
|-
|  || CARDIOLOGY || VTE || Khorana risk score for venous thromboembolism in cancer patients ||  ||  ||  || Tier 1
|-
|  || CARDIOLOGY || Coronary artery disease || Killip classification for heart failure ||  ||  ||  || Tier 2
|-
|  || CARDIOLOGY ||  || LACE Index for Readmission ||  ||  ||  ||
|-
| Formula || CARDIOLOGY || Coronary artery disease || LDL calculated ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || Light's Criteria for Exudative Effusions ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || MAGGIC Risk Calculator for Heart Failure ||  ||  ||  ||
|-
|  || CARDIOLOGY || Coronary artery disease || Marburg Heart Score (MHS) ||  ||  ||  || Tier 1
|-
| Formula || CARDIOLOGY || Blood pressure || Mean Arterial Pressure (MAP) ||  ||  ||  ||
|-
|  || CARDIOLOGY ||  || Mehran Score for Post-PCI Contrast Nephropathy ||  ||  ||  ||
|-
|  || CARDIOLOGY || VTE || Michigan risk score for picc-related thrombosis ||  ||  ||  || Tier 1
|-
|  || CARDIOLOGY ||  || mMRC (Modified Medical Research Council) Dyspnea Scale ||  ||  ||  ||
|-
|  || CARDIOLOGY || Coronary artery disease || Modified Early Warning Score (MEWS) for clinical deterioration ||  ||  ||  || Tier 1
|-
|  || CARDIOLOGY ||  || Modified SOAR Score for Stroke ||  ||  ||  ||
|-
| || CARDIOLOGY || DVT || Modified Wells score calculator for DVT ||  || Sadaf Sharfaei ||  || Complete
|-
|  || CARDIOLOGY || Coronary artery disease || National Early Warning Score (NEWS) ||  ||  ||  || Tier 1
|-
|  || CARDIOLOGY || Coronary artery disease || National Early Warning Score (NEWS) 2 ||  ||  ||  || Tier 1
|-
|  || CARDIOLOGY ||  || Newsom Score for Non-traumatic Chest Pain ||  ||  ||  ||
|}
|}

Latest revision as of 20:26, 15 June 2020

Definition of Multivessel Disease

For AEGIS-II inclusion criteria #5, multivessel disease criteria can be met by findings on the cardiac catheterization for the index MI, a prior cardiac catheterization, or both:

  • Index MI cardiac catheterization: 50% or greater stenosis of the left main or at least 2 coronary artery territories (LAD, LCX, RCA) (prior to any interventions performed)
  • Prior cardiac catheterization: 50% or greater stenosis of left main or at least 2 coronary artery territories (LAD, LCx, RCA) (prior to any interventions performed)
  • Both: Index MI cardiac catheterization with 1 vessel with 50% or greater stenosis (prior to any interventions performed) AND prior PCI of at least 1 vessel different from index MI vessel
  • Prior multivessel CABG

Multivessel disease requires a 50% or greater stenosis in at least 2 of the 3 major epicardial artery territories (LAD, LCx, RCA) or the left main vessel. Branch vessel disease may qualify as part of the territory of that branch vessel (for example, a diagonal vessel is considered part of the LAD territory). For the purpose of this study, the ramus is considered part of the Left Circumflex artery territory. If a branch vessel is used as a qualifying vessel, that branch should be of large enough size to potentially undergo revascularization if clinically indicated, e.g. >2mm vessel size.

MVD Tool

Multivessel Disease Tool
To determine if your patient meets the eligibility criteria for multivessel disease, please check all arteries/segments with 50% or greater stenosis on the cardiac catheterization for index MI and/or vessels that have received prior PCI (stent or balloon angioplasty).
Left Main Coronary Artery Left Main Artery
Left Anterior Descending Artery Proximal LAD
Middle LAD
Distal LAD
First Diagonal Artery
Second Diagonal Artery
Third Diagonal Artery
Circumflex Artery Proximal Cx
Middle Cx
Distal Cx
First Obtuse Marginal Artery
Second Obtuse Marginal Artery
Third Obtuse Marginal Artery
Left Posterior Descending Artery
Left Posterior Atrioventricular Artery
Left Posterolateral Artery
Ramus Intermedius Artery
Right Coronary Artery Proximal RCA
Middle RCA
Distal RCA
Right Posterior Descending Artery
Right Posterior Atrioventricular Artery
Right Posterolateral Artery
Prior Multivessel Coronary Artery Bypass Grafting
Interpretation: